Abstract | INTRODUCTION: Notch is a family of transmembrane protein receptors whose activation requires proteolytic cleavage by gamma-secretase. Since aberrant Notch signaling can induce mammary carcinomas in transgenic mice and high expression levels of Notch receptors and ligands correlates with overall poor clinical outcomes, inhibiting gamma-secretase with small molecules may be a promising approach for breast cancer treatment. Consistent with this hypothesis, two recent papers reported that gamma-secretase inhibitor I (GSI I), Z-LLNle-CHO, is toxic to breast cancer cells both in vitro and in vivo. In this study, we compared the activity and cytotoxicity of Z-LLNle-CHO to that of two highly specific GSIs, DAPT and L-685,458 and three structurally unrelated proteasome inhibitors, MG132, lactacystin, and bortezomib in order to study the mechanism underlying the cytotoxicity of Z-LLNle-CHO in breast cancer cells. METHODS: Three estrogen receptor (ER) positive cell lines, MCF-7, BT474, and T47D, and three ER negative cell lines, SKBR3, MDA-MB-231, and MDA-MB-468, were used in this study. Both SKBR3 and BT474 cells also overexpress HER2/neu. Cytotoxicity was measured by using an MTS cell viability/proliferation assay. Inhibition of gamma-secretase activity was measured by both immunoblotting and immunofluorescent microscopy in order to detect active Notch1 intracellular domain. Proteasome inhibition was determined by using a cell-based proteasome activity assay kit, by immunoblotting to detect accumulation of polyubiquitylated protein, and by immunofluorescent microscopy to detect redistribution of cellular ubiquitin. RESULTS: CONCLUSIONS:
|
Authors | Jianxun Han, Ivy Ma, Michael J Hendzel, Joan Allalunis-Turner |
Journal | Breast cancer research : BCR
(Breast Cancer Res)
Vol. 11
Issue 4
Pg. R57
( 2009)
ISSN: 1465-542X [Electronic] England |
PMID | 19660128
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Carbamates
- Dipeptides
- Estrogens
- L 685458
- N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester
- NOTCH1 protein, human
- Neoplasm Proteins
- Oligopeptides
- Proteasome Inhibitors
- Receptor, Notch1
- Receptors, Estrogen
- benzyloxycarbonyl-leucyl-leucyl-norleucinal
- Amyloid Precursor Protein Secretases
- Proteasome Endopeptidase Complex
|
Topics |
- Adenocarcinoma
(enzymology, pathology)
- Amyloid Precursor Protein Secretases
(antagonists & inhibitors)
- Breast Neoplasms
(enzymology, pathology)
- Carbamates
(pharmacology)
- Cell Line, Tumor
(drug effects, enzymology, pathology)
- Dipeptides
(pharmacology)
- Drug Delivery Systems
- Estrogens
- Female
- Humans
- Neoplasm Proteins
(analysis, antagonists & inhibitors, metabolism)
- Neoplasms, Hormone-Dependent
(enzymology, pathology)
- Oligopeptides
(pharmacology, toxicity)
- Proteasome Endopeptidase Complex
(drug effects)
- Proteasome Inhibitors
- Receptor, Notch1
(metabolism)
- Receptors, Estrogen
(analysis)
|